Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
fccp A series of monocarboxylated chalcones e g compounds
2020-07-27

A series of monocarboxylated chalcones (e.g. compounds 7 and 8, Fig. 2A) was previously identified as good CysLT1 antagonists [20], and none of them exhibited CysLT2 antagonistic activities (Supplementary Table S1). This study was consistent with reported result that CysLT2 fccp was not sensitive to
-
Mounting evidences show that the
2020-07-27

Mounting evidences show that the Quinidine glutamate metabolism plays an essential role in the pathophysiology of epilepsy. Administrating glutamate to experimental animals can contribute to seizure onset [3], by contrast, the symptom of seizures alleviated by coadministration of glutamate antagoni
-
Based on published reports and our own findings
2020-07-27

Based on published reports and our own findings, we propose to combine genetic inactivation with pharmacological inhibition in mechanistic studies because the selectivity of many commercially available inhibitors is often limited. Experiments with non-selective inhibitors easily lead to misleading c
-
Identification of the phosphosites on CDK Next we wished
2020-07-27

Identification of the phosphosites on CDK5: Next we wished to identify the phosphosites on CDK5. To do so, we performed an in vitro kinase assay on the commercially available recombinant His6-CDK5 and GST-p35 complex (Fig. S1A). A total of seven residues on CDK5 were identified as putative phosphosi
-
Rose Bengal Collectively our structures offer novel structur
2020-07-27

Collectively, our structures offer novel structural insights into the action of diverse CRTH2 antagonists, which will facilitate CRTH2 drug development for a number of inflammatory diseases, including asthma. They also reveal interesting features of the ligand binding pocket and suggest a novel mech
-
Introduction Since the recognition of AIDS in more
2020-07-27

Introduction Since the recognition of AIDS in 1981 more than thirty-five years ago, nearly 70 million individuals have been infected with human immunodeficiency virus type 1 (HIV) and roughly half have died (http://www.unaids.org/en/resources/documents/2016/AIDS-by-the-numbers). Although the introd
-
br General mechanism of NHEJ NHEJ is an amazingly versatile
2020-07-25

General mechanism of NHEJ NHEJ is an amazingly versatile pathway that can select specific enzymes which bind to, process, and finally mediate the direct re-ligation of a wide range of DSBs including those that are complex, have incompatible ends, and contain Berberine Sulfate damages [7], [8], [
-
Although high concentrations of SCR G and SCR R inhibited
2020-07-25

Although high concentrations of SCR7-G and SCR7-R inhibited LigIV as reported [11], the SCR7 derivatives were more effective inhibitors of LigIIIα and, in particular, LigI. Although it is possible that differences in the DNA substrate underlie this discrepancy, it appears more likely that this refle
-
We have previously reported DAPK inhibitors discovered
2020-07-25

We have previously reported DAPK inhibitors discovered through our structure-based virtual screening (SBVS) research program. In this paper, we describe the general protocol of our in silico approach, and the strategy used to develop hit compounds. In addition, the studies conducted on the structure
-
br Conclusions In a former study we compared the modulating
2020-07-25

Conclusions In a former study we compared the modulating potential of halogenated 1H-benzimidazole derivatives towards CK2 catalytic subunits. Now we were interested if similar differences are also obtained using completely different substances. Some of these natural occurring compounds were alre
-
In this study we examined a possible
2020-07-25

In this study, we examined a possible association between the 19-bp hyPerFUsion™ high-fidelity DNA polymerase mg and the 9-bp repeat in the DHFR gene and the risk of spina bifida in 121 mothers of a spina bifida affected child, 292 control women, 109 spina bifida patients and 234 pediatric controls
-
Phosphate Colorimetric Assay Kit DDR distribution in healthy
2020-07-25

DDR1 distribution in healthy, fibrotic and inflamed tissues Whereas we can easily mine publicly available databases to infer DDR1 expression profile in different tissues (as reported in Fig. 1), fine comprehension of DDR1 biology has been hampered by the absence of a commercially available specific
-
We then undertook computational studies that suggest the cya
2020-07-25

We then undertook computational studies that suggest the cyanobacterial ALDH (and planctomyces ALDH) represent the evolutionary ancestor of human and other eukaryotic ALDH1/2 given that cfALDH contains signature residues matching both the human proteins throughout the surface of the protein and the
-
br Acknowledgments This research was supported
2020-07-24

Acknowledgments This research was supported by grants from the Ministerio de Ciencia e Innovación (Grants SAF/FEDER 2010-17907; 2013-49076-P), Spain, Red de trastornos adictivos (RETICS RD12/0028//0003, Instituto de Salud Carlos III, Spain) and Fundación Séneca (15405/PI/10, Región de Murcia, Spa
-
br Methods br Discussion and
2020-07-24

Methods Discussion and conclusions There were no statistically significant differences in pulmonary function outcomes (FEV1 and FVC) between the placebo and BAY 85-8501 treatment groups. The decline in mean FEV1 from baseline to EOT in the placebo group was attributed statistically to a few pa
14536 records 805/970 page Previous Next First page 上5页 801802803804805 下5页 Last page